Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -95,135 | -132,710 | N/A | N/A |
| Depreciation Amortization | 11,525 | 11,764 | N/A | N/A |
| Accounts receivable | -683 | 2,334 | N/A | N/A |
| Accounts payable and accrued liabilities | -4,846 | 12,700 | N/A | N/A |
| Other Working Capital | -36,983 | -12,887 | N/A | N/A |
| Other Operating Activity | 48,345 | -10,649 | 0 | 0 |
| Operating Cash Flow | $-77,777 | $-129,447 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -3,080 | -5,103 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -253 | N/A | N/A |
| Other Investing Activity | 3,680 | -180 | 0 | 0 |
| Investing Cash Flow | $600 | $-5,283 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 106,946 | 76,488 | N/A | N/A |
| Other Financing Activity | 41,923 | -6,096 | 0 | 0 |
| Financing Cash Flow | $148,868 | $70,392 | $N/A | $N/A |
| Exchange Rate Effect | -108 | -42 | N/A | N/A |
| Beginning Cash Position | 94,972 | 158,827 | N/A | N/A |
| End Cash Position | 166,555 | 94,447 | N/A | N/A |
| Net Cash Flow | $71,583 | $-64,380 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -77,777 | -129,447 | N/A | N/A |
| Capital Expenditure | -3,947 | -5,207 | N/A | N/A |
| Free Cash Flow | -81,724 | -134,654 | 0 | 0 |